Consun Pharmaceutical Group

1681 · HKEX

Public Market Listing

1681HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Consun Pharmaceutical Group are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Phase 1
Soluble guanylate cyclaseSmall molecule
Chronic Kidney Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (5 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$476M—$176M—report ↗
View 4 more years
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$413M—$398M—report ↗
2023-FY$366M—$387M—report ↗
2022-FY$348M—$352M—report ↗
2021-FY$317M—$345M—report ↗